Despite its vast potential for alleviating human suffering, turmeric will likely never receive the FDA stamp of approval, due to its lack of exclusivity, patentability and therefore profitability. Truth be told, the FDA's "gold standard" for proving the value of a prospective medicinal substance betrays the age old aphorism: "he who owns the gold makes the rules," and unless an investor is willing to risk losing the 800+ million dollars that must be spent upfront, the FDA-required multi-phased double-blind, randomized clinical trials will not occur. For additional details on this rather seedy arrangement read our article on the topic: Why The Law Forbids The Medicinal Use of Natural